Venous Thromboembolism News and Research

RSS
New clinical practice guidelines for managing venous thromboembolism released

New clinical practice guidelines for managing venous thromboembolism released

New diabetes drugs linked to increased risk of lower-limb amputation and ketoacidosis

New diabetes drugs linked to increased risk of lower-limb amputation and ketoacidosis

TherapeuticsMD announces FDA approval of BIJUVA capsules to manage vasomotor symptoms of menopause

TherapeuticsMD announces FDA approval of BIJUVA capsules to manage vasomotor symptoms of menopause

Aspirin may be effective in preventing blood clots after knee replacement

Aspirin may be effective in preventing blood clots after knee replacement

Exelixis presents CABOSUN and METEOR trial results in patients with advanced renal cell carcinoma

Exelixis presents CABOSUN and METEOR trial results in patients with advanced renal cell carcinoma

New standard of care aims to prevent deaths caused by largely preventable blood clots

New standard of care aims to prevent deaths caused by largely preventable blood clots

New inflammatory biomarker correlates with increased thrombosis risk in cancer patients

New inflammatory biomarker correlates with increased thrombosis risk in cancer patients

Recurrence risk of VTE appears similar for patients with cancer and those with unprovoked VTE

Recurrence risk of VTE appears similar for patients with cancer and those with unprovoked VTE

Genes predicting person's height may provide clues about causes of varicose veins

Genes predicting person's height may provide clues about causes of varicose veins

Ipsen receives approval from Health Canada for CABOMETYX tablets for treating renal cell carcinoma

Ipsen receives approval from Health Canada for CABOMETYX tablets for treating renal cell carcinoma

NCCN updates Clinical Practice Guidelines to include new recommendations for CABOMETYX tablets

NCCN updates Clinical Practice Guidelines to include new recommendations for CABOMETYX tablets

Antithrombin drug does not reduce risk of myocardial infarction, stroke in heart failure patients

Antithrombin drug does not reduce risk of myocardial infarction, stroke in heart failure patients

Oral anticoagulant use after hospital discharge may offer protection from non-fatal blood clots

Oral anticoagulant use after hospital discharge may offer protection from non-fatal blood clots

FDA approves first vaginal ring contraceptive that can be used for one year

FDA approves first vaginal ring contraceptive that can be used for one year

Transgender individuals may be at higher risk for cardiovascular disease

Transgender individuals may be at higher risk for cardiovascular disease

Depression, antidepressant use linked with higher risk of venous thromboembolism

Depression, antidepressant use linked with higher risk of venous thromboembolism

Researchers develop new model for predicting cancer-associated venous thrombosis

Researchers develop new model for predicting cancer-associated venous thrombosis

Direct oral anticoagulants associated with reduced risks of major bleeding

Direct oral anticoagulants associated with reduced risks of major bleeding

Risk of heart attacks, strokes and vascular occlusions found to be higher in cancer patients

Risk of heart attacks, strokes and vascular occlusions found to be higher in cancer patients

Oral drug reduces venous thromboembolism recurrence among cancer patients

Oral drug reduces venous thromboembolism recurrence among cancer patients